Jupiter Neurosciences, Inc. (JUNS) income statement
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.52+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.17MP/E –Yield –
Jupiter Neurosciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 80.6%
- Operating margin
- -45016.4%
- Net margin
- -42206.9%
- Return on equity, FY2025
- -738.8%
Financial strength
- Current ratio
- 0.66
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 39.2%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?